Comparison of propofol and etomidate in patients posted under general anaesthesia

A COMPARISON BETWEEN PROPOFOL AND ETOMIDATE AS AN INDUCTION AGENT DURING GENERAL ANESTHESIA - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099022

Enrollment

150

Registered

2025-12-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Etomidate: Premedication With Midazolam 1mg IV, Glycopyrrolate 0.02mg IV And Fentanyl (1-2mcg/kg) IV . Subsequently, Etomidate 0.3 mg/kg IV Bolus Will Be Administered Intravenously As

Eligibility

Inclusion criteria

Inclusion criteria: Age Between 18 to 65 Years ASA Physical Status I or II Patients Posted For Elective Surgical Procedures Under General Anesthesia Patients Willing To Give Informed Consent.

Exclusion criteria

Exclusion criteria: ASA Grade III Or Higher Known Or Suspected Adrenal Insufficiency Or Sepsis Patients With Known History Of Allergy To Egg Or Study Drugs. Pregnancy Or Lactation Patients Not Giving Informed Consent.

Design outcomes

Primary

Measure	Time frame
To Observe ,Record And Compare Hemodynamic Parameters In Two Group Of Patients Receiving Propofol And Etomidate As An Induction Agent.Timepoint: 60 Min	—

Secondary

Measure	Time frame
To Assess And Compare Time Required To Reach The Induction Between Propofol And EtomidateTimepoint: 60 Min	—

Countries

India

Contacts

Public ContactCH HARSH PRATAP SINGH LODHI

Peoples College Of Medical Sciences And Research Centre Bhanpul Bhopal

akankshaagarwal2020@gmail.com8989147838

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026